Curekey medical guide·6 min read

Finasteride for Hair Loss

An evidence-based overview of finasteride for pattern hair loss, including how it works, what to expect, side-effect considerations, dosing, and how it compares to other treatments.

Finasteride for Hair Loss

Finasteride for hair loss is one of the most studied oral therapies in the management of androgenetic alopecia, with more than three decades of clinical data supporting its use in men. It was the first systemic medication approved by the FDA specifically for pattern hair loss, and it remains a cornerstone of evidence-based care today. This guide brings together what patients most often want to understand before starting treatment, including the underlying biology, the realistic course of results, the risks worth knowing, and how finasteride fits alongside other options like minoxidil and dutasteride.

The goal here is not to promote any particular outcome. Pattern hair loss is a chronic biological process, and treatment decisions belong to a patient and their physician working together. What we can offer is a clear, current summary of how finasteride works and what published research suggests about its effects.

How finasteride works

Pattern hair loss in men is driven primarily by the influence of dihydrotestosterone, or DHT, on genetically susceptible scalp follicles. DHT is a more potent androgen than testosterone, and it is produced when the enzyme 5-alpha-reductase converts testosterone in target tissues. In follicles sensitive to DHT, repeated exposure shortens the anagen (growth) phase of the hair cycle and gradually shrinks the follicle itself, a process known as follicle miniaturization.

Finasteride is a selective inhibitor of the Type 2 isoform of 5-alpha-reductase, which is the dominant form expressed in scalp follicles. By inhibiting this enzyme, finasteride lowers serum DHT by roughly 65 to 70 percent at the standard 1 mg daily dose. The clinical consequence is that susceptible follicles are exposed to less DHT, which slows or halts miniaturization and, in many cases, allows partially miniaturized follicles to recover.

Importantly, finasteride does not raise testosterone meaningfully outside of normal physiologic ranges, and it does not affect the Type 1 enzyme that predominates in skin and sebaceous glands. This selective action is part of why finasteride is generally considered to have a more targeted side-effect profile than dual-inhibitor therapies, though as discussed below, side effects are still possible and worth understanding.

Who finasteride is generally considered for

Finasteride is approved for men with androgenetic alopecia, typically those experiencing visible thinning, receding hairline, or crown thinning consistent with pattern loss. The medication has the strongest evidence in men aged 18 to 41 in the original phase III trials, though it continues to be used in older men under physician supervision.

Finasteride is not generally prescribed to women of reproductive age and is contraindicated in pregnancy. Crushed or broken tablets must not be handled by women who are or may become pregnant, because finasteride is teratogenic and can affect the development of a male fetus. For women, alternative androgen-pathway treatments are sometimes considered under specialist care.

Whether finasteride is appropriate in any specific situation is a clinical judgment. A telehealth or in-person visit is the right place to weigh personal medical history, family history, the stage of hair loss, and patient priorities.

What clinical evidence shows

The pivotal trials supporting finasteride for hair loss were five-year randomized, placebo-controlled studies published in J Am Acad Dermatol and other peer-reviewed journals. Across these trials, men taking finasteride 1 mg daily showed measurable improvements over placebo in hair count, patient self-assessment, investigator assessment, and global photo grading.

Two findings from the long-term data are particularly worth understanding. First, the most consistent effect of finasteride is the prevention of further loss. In long-term follow-up, the placebo group continued to lose hair on a predictable trajectory, while the finasteride group remained stable or improved. Second, regrowth, when it occurs, is most commonly seen at the vertex and mid-scalp. The hairline can also respond, but generally to a lesser degree.

Patient-reported outcomes from the same trials suggested that the majority of men noticed at least some improvement, with a smaller subset describing a clearly visible difference. A meaningful minority did not see a noticeable change but still benefited from the slowing of progression. We discuss the practical implications of this in Finasteride Before and After.

Common questions before starting

Patients considering finasteride often share a similar set of questions. The cluster pages linked below address each in more depth, but here is a brief orientation.

Will I shed hair when I start?

A subset of patients experience a temporary increase in shedding in the early weeks or months. This is biologically related to follicles synchronizing into the next growth cycle and is generally considered a sign that treatment is engaging the hair cycle. It typically resolves within 4 to 8 weeks. See Finasteride Shedding for the full picture.

How long until I see results?

Finasteride works gradually. Internal DHT suppression begins within days, but visible change at the scalp lags by months because hair growth itself is slow. Most clinical trials measured outcomes at 6 and 12 months for that reason. Our Finasteride Timeline walks through expectations month by month.

What side effects should I know about?

The most discussed side effects involve sexual function and mood. Trial data and post-marketing surveillance both inform what we know, and the picture is more nuanced than headlines often suggest. See Finasteride Side Effects for an evidence-based breakdown.

What does success actually look like?

Realistic expectations matter. The most common outcome is stabilization with modest visible improvement, not a complete reversal of pattern loss. Finasteride Before and After discusses how to interpret photos and assess your own response.

What's the right dose?

The FDA-approved dose for hair loss is 1 mg daily. There is growing research interest in lower-dose protocols, but dosing decisions belong with a physician. See Finasteride Dosage for what the evidence shows.

How does it compare to dutasteride?

Dutasteride is a related but more potent dual inhibitor used off-label for hair loss in some cases. Finasteride vs. Dutasteride examines the trade-offs.

How finasteride fits with other treatments

Finasteride is often used alongside topical or oral minoxidil, which works through a separate mechanism. Combining a DHT-pathway treatment with a follicle-stimulating treatment is a common clinical approach, because the two address different drivers of the same condition. For some patients, monotherapy with finasteride is sufficient; for others, combination therapy is more appropriate. The choice depends on the stage of hair loss, individual response, and physician judgment.

For a deeper look at the underlying biology of how finasteride affects the hair cycle, our companion guide How Finasteride Treats Hair Loss is a useful next read.

What happens if you stop

Like other DHT-pathway treatments, finasteride works only while you take it. If finasteride is discontinued, DHT levels return to baseline within roughly two weeks, and the underlying pattern hair loss process resumes. Hair gained or maintained on treatment is generally lost over the following 6 to 12 months. This is covered in more detail in What Happens If You Stop Treatment, and it is one of the reasons that ongoing care, rather than short courses of treatment, is the standard approach for chronic conditions like androgenetic alopecia.

Considering medical assessment

Pattern hair loss is a chronic condition, and finasteride is a long-term medication, so the decision to start is best made with a physician who can review your medical history, discuss the trade-offs, and arrange appropriate monitoring. A clinical assessment can also confirm that pattern hair loss is the right diagnosis, since other conditions like telogen effluvium, alopecia areata, or thyroid-related shedding can mimic or compound it.

If you are considering treatment, the How Curekey Works page outlines our medical model: licensed physicians, evidence-based protocols, and ongoing follow-up rather than one-off prescriptions. Whether or not Curekey is the right fit for you, the most important step is getting a proper evaluation before starting any prescription medication.

Happy customer

Start your online medical assessment

Start with a quick medical assessment, fully online

Start assessment